From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
主要な著者: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Frontiers Media
2021
|
類似資料
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
著者:: Bowness, P
出版事項: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
著者:: Shi, H, 等
出版事項: (2020) -
The immunology of Ankylosing Spondylitis
著者:: Bowness, P
出版事項: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
著者:: Voruganti, A, 等
出版事項: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
著者:: Fischer, R, 等
出版事項: (2012)